Follow
Stephen L. Hauser
Stephen L. Hauser
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Nature 476 (7359), 214-219, 2011
29392011
B-cell depletion with rituximab in relapsing–remitting multiple sclerosis
SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ...
New England Journal of Medicine 358 (7), 676-688, 2008
27122008
Ocrelizumab versus placebo in primary progressive multiple sclerosis
X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ...
New england journal of medicine 376 (3), 209-220, 2017
18552017
Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis
SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ...
New England Journal of Medicine 376 (3), 221-234, 2017
17592017
Sequential vs concurrent chemoradiation for stage III non–small cell lung cancer: randomized phase III trial RTOG 9410
WJ Curran Jr, R Paulus, CJ Langer, R Komaki, JS Lee, S Hauser, ...
Journal of the National Cancer Institute 103 (19), 1452-1460, 2011
13702011
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ...
Nature genetics 45 (11), 1353-1360, 2013
13172013
Identification of autoantibodies associated with myelin damage in multiple sclerosis
CP Genain, B Cannella, SL Hauser, CS Raine
Nature medicine 5 (2), 170-175, 1999
10951999
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double‐blind placebo‐controlled multicenter trial
K Hawker, P O'Connor, MS Freedman, PA Calabresi, J Antel, J Simon, ...
Annals of neurology 66 (4), 460-471, 2009
10192009
The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration
SL Hauser, JR Oksenberg
Neuron 52 (1), 61-76, 2006
10162006
Intensive immunosuppression in progressive multiple sclerosis: a randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH
SL Hauser, DM Dawson, JR Lehrich, MF Beal, SV Kevy, RD Propper, ...
New England Journal of Medicine 308 (4), 173-180, 1983
10131983
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
PL De Jager, X Jia, J Wang, PIW De Bakker, L Ottoboni, NT Aggarwal, ...
Nature genetics 41 (7), 776-782, 2009
9772009
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
L Kappos, D Li, PA Calabresi, P O'Connor, A Bar-Or, F Barkhof, M Yin, ...
The Lancet 378 (9805), 1779-1787, 2011
9242011
Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models
E Cekanaviciute, BB Yoo, TF Runia, JW Debelius, S Singh, CA Nelson, ...
Proceedings of the National Academy of Sciences 114 (40), 10713-10718, 2017
8682017
A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex
JL Haines, M Ter-Minassian, A Bazyk, JF Gusella, DJ Kim, H Terwedow, ...
Nature genetics 13 (4), 469-471, 1996
8241996
Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis
SG Gregory, S Schmidt, P Seth, JR Oksenberg, J Hart, A Prokop, ...
Nature genetics 39 (9), 1083-1091, 2007
8222007
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
8202019
Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome
DT Okuda, EM Mowry, A Beheshtian, E Waubant, SE Baranzini, ...
Neurology 72 (9), 800-805, 2009
7112009
T cell gelatinases mediate basement membrane transmigration in vitro.
D Leppert, E Waubant, R Galardy, NW Bunnett, SL Hauser
Journal of immunology (Baltimore, Md.: 1950) 154 (9), 4379-4389, 1995
6291995
Treatment of multiple sclerosis: a review
SL Hauser, BAC Cree
The American journal of medicine 133 (12), 1380-1390. e2, 2020
6032020
Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?
A Bar‐Or, L Fawaz, B Fan, PJ Darlington, A Rieger, C Ghorayeb, ...
Annals of neurology 67 (4), 452-461, 2010
5712010
The system can't perform the operation now. Try again later.
Articles 1–20